Over more than eight years of monitoring, getting familiar with the EU CTR, conducting trial submissions activities, etc., ...

In phase 3 cancer trials, toxicity data are “often incompletely reported” and “frequently minimized,” according to researchers.

This article will explore what DLBCL is and how clinical trials can potentially lead to breakthroughs in treatment.

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

“Dosing of the first patient in the CTIM-76 Phase 1 trial represents a key advancement of our clinical pipeline,” said Martin Lehr, CEO of Context. “We recently presented at the 39th Annual Meeting of ...

Neumora Therapeutics’ phase 3 fail was worse than analysts feared. | Neumora Therapeutics’ phase 3 fail was worse than ...

Researchers have applied AI to every step of the drug development process. But this might not be enough to design safe and ...

Explore how MRI imaging acts as a pivotal scientific hub, bridging the gap between preclinical and clinical research to drive ...

Tris Pharma has pointed to a phase 3 win for its pain relief drug as demonstrating the candidate’s potential to help resolve the opioid crisis. | Tris Pharma has pointed to a phase 3 win for its pain ...

In July 2024, BioNTech announced positive topline data from an ongoing Phase 2 clinical trial involving patients with unresectable stage III or IV melanoma whose disease had progressed following ...

Rachel Leheny, Ph.D., CEO of CalciMedica, expressed confidence in Dr. Glicklich's ability to guide the company through its next phase of clinical trials. She highlighted his impressive track ...